文献速递慢性肾脏病肾小球疾病

美国2009-2014年糖尿病与慢性肾脏病的人群关联研究

Diabetes and CKD in the United States Population, 2009-2014.
PubMed 文献 · Clin J Am Soc Nephrol · 2017-10-20

该横断面研究纳入NHANES 2009-2014的15675名参与者,比较糖尿病患者与非糖尿病患者的CKD表现患病率。糖尿病患者任何CKD患病率为25% vs 5.3%,白蛋白尿和eGFR降低均更常见,且独立于人口学与血压因素;约24%的美国成人CKD可归因于糖尿病。

要点

  • 糖尿病患者CKD患病率显著高于非糖尿病患者(25% vs 5.3%)。
  • 糖尿病与白蛋白尿及eGFR降低的关联独立于人口学和血压。
  • 约24%的美国成人CKD归因于糖尿病。

核心结论

  • 糖尿病与白蛋白尿和GFR降低强烈相关,且独立于人口学和高血压,对美国CKD负担贡献显著。

研究设计与样本

  • 横断面研究,纳入2009-2014年NHANES的15675名参与者。
  • 糖尿病定义为使用降糖药或HbA1c≥6.5%。
  • eGFR采用CKD-EPI公式计算,尿白蛋白肌酐比来自单次尿样。

主要发现

  • 糖尿病患者(n=2279)vs 非糖尿病(n=13396)任何CKD患病率25% vs 5.3%(P<0.001)。
  • ACR≥30 mg/g患病率16% vs 3.0%;ACR≥300 mg/g为4.6% vs 0.3%(均P<0.001)。
  • eGFR<60 ml/min/1.73m2患病率12% vs 2.5%;eGFR<30为2.4% vs 0.4%(均P<0.001)。
  • 调整人口学和血压后,患病率差异分别为14.6%、10.8%、4.5%、6.5%、1.8%(P值分别<0.001、<0.001、<0.001、<0.001、0.004)。
  • 调整人口学后,约24%(95%CI 19%-29%)的美国成人CKD归因于糖尿病。

临床怎么用

  • 在糖尿病患者中应筛查白蛋白尿和eGFR以识别CKD。
  • 评估CKD归因时需考虑糖尿病独立于高血压的贡献。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Diabetes is an important cause of CKD. However, among people with diabetes, it is unclear to what extent CKD is attributable to diabetes itself versus comorbid conditions, such as advanced age and hypertension. We examined associations of diabetes with clinical manifestations of CKD independent of age and BP and the extent to which diabetes contributes to the overall prevalence of CKD in the United States. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We performed a cross-sectional study of 15,675 participants in the National Health and Nutrition Examination Surveys from 2009 to 2014. Diabetes was defined by use of glucose-lowering medications or hemoglobin A1c ≥6.5%. eGFR was calculated using the CKD Epidemiology Collaboration formula, and albumin-to-creatinine ratio was measured in single-void urine samples. We calculated the prevalence of CKD manifestations by diabetes status as well as prevalence ratios, differences in prevalence, and prevalence attributable to diabetes using binomial and linear regression, incorporating data from repeat eGFR and urine albumin-to-creatinine ratio measurements to estimate persistent disease. RESULTS: For participants with diabetes (n=2279) versus those without diabetes (n=13,396), the estimated prevalence of any CKD (eGFR<60 ml/min per 1.73 m2; albumin-to-creatinine ratio ≥30 mg/g, or both) was 25% versus 5.3%, respectively; albumin-to-creatinine ratio ≥30 mg/g was 16% versus 3.0%, respectively; albumin-to-creatinine ratio ≥300 mg/g was 4.6% versus 0.3%, respectively; eGFR<60 ml/min per 1.73 m2 was 12% versus 2.5%, respectively; and eGFR<30 ml/min per 1.73 m2 was 2.4% versus 0.4%, respectively (each P<0.001). Adjusting for demographics and several aspects of BP, prevalence differences were 14.6% (P<0.001), 10.8% (P<0.001), 4.5% (P<0.001), 6.5% (P<0.001), and 1.8% (P=0.004), respectively. Approximately 24% (95% confidence interval, 19% to 29%) of CKD among all United States adults was attributable to diabetes after adjusting for demographics. CONCLUSIONS: Diabetes is strongly associated with both albuminuria and reduced GFR independent of demographics and hypertension, contributing substantially to the burden of CKD in the United States.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Zelnick LR, Weiss NS, Kestenbaum BR, et al. Diabetes and CKD in the United States Population, 2009-2014. Clin J Am Soc Nephrol. 2017. PMID: 29054846. doi:10.2215/CJN.03700417

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。